Professor of Neurology, Case West Res University
Neurology
Dr. Peter J. Whitehouse, MD
|
|
Give Review
Peter Whitehouse practices Neurology. He graduated from Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a one of the best medicals schools. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He has 1 awards "Regional Top Doctor". Peter Whitehouse has written publications. He has 71 publications published with PubMed. The lastest publication is: 'Differential diagnosis of Alzheimer's disease.'
Publications
- From Neurodegeneration to Brain Health: An Integrated Approach.
- A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's Disease.
- Adapting to Dementia in Society: A Challenge for Our Lifetimes and a Charge for Public Health.
- Alzheimer's Disease cooperative study prevention instrument project assessing resource use and volunteer and paid work in healthy elders: a longitudinal study.
- The end of Alzheimer's Disease-From biochemical pharmacology to ecopsychosociology: A personal perspective.
- Chasing the "white whale" of Alzheimer's.
- The Challenges of Cognitive Aging: Integrating Approaches from Science to Intergenerational Relationships.
- Health-Related Resource Use and Costs in Elderly Adults with and without Mild Cognitive Impairment.
- Further Limits on Labels for Cognitive Impairment: Can We Diagnose What We Don't Know?
- Uncertain Progress on the Fuzzy Boundaries of Alzheimer's Disease: Reading Between the Guidelines.
- The Evolving Classification of Dementia: Placing the DSM-V in a Meaningful Historical and Cultural Context and Pondering the Future of "Alzheimer's"
- Marketplace of Memory: What the Brain Fitness Technology Industry Says About Us and How We Can Do Better.
- The future of Dementia: a case of hardening of the categories.
- Intergenerational volunteering and quality of life for persons with mild-to-moderate Dementia: results from a 5-month intervention study in the United States.
- Variable judgments of decisional capacity in cognitively impaired research subjects.
- Incorporating ethnicity into genetic risk assessment for Alzheimer Disease: the REVEAL study experience.
- Health state valuation in mild to moderate cognitive impairment: feasibility of computer-based, direct patient utility assessment.
- Dementia, diagnostic disclosure, and self-reported health status.
- Empirical assessment of a research advance directive for persons with Dementia and their proxies.
- Involuntary emotional expressive disorder: a case for a deeper neuroethics.
- Commentary: integrative narrative evolutionary health: toward a wiser view of Alzheimer's Disease.
- Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's Disease: the REVEAL Study.
- The end of AD. Part 3.
- ADCS Prevention Instrument Project: pilot testing of a book club as a psychosocial intervention and recruitment and retention strategy.
- Antiaging medicine and mild cognitive impairment: practice and policy issues for geriatrics.
- Who seeks genetic susceptibility testing for Alzheimer's Disease? Findings from a multisite, randomized clinical trial.
- Anti-aging medicine: can consumers be better protected?
- Justice and the house of medicine: the mortgaging of ecology and economics.
- Quality of life in Dementia: ten years later.
- Empirical research on informed consent with the cognitively impaired.
- MSJAMA: Lessons and responses in Alzheimer Disease research.
- Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer Disease.
- The rebirth of bioethics: extending the original formulations of Van Rensselaer Potter.
- Informed consent for Alzheimer's Disease clinical trials: a survey of clinical investigators.
- The evolution of gene patenting.
- Van Rensselaer Potter: an intellectual memoir.
- Readdressing our moral relationship to nonhuman creatures: commentary on "A dialogue on species-specific rights: humans and animals in bioethics.
- Discourse ethics: research, Dementia, and communication.
- Guidelines for addressing ethical and legal issues in Alzheimer Disease research: a position paper.
- Special care unit research: ethical issues.
- Introduction (to 6 articles and a position paper on ethical and legal issues in Alzheimer Disease research)
- Differential diagnosis of Alzheimer's Disease.
- Empowering whom? Neuroethics at its limits.
- Design considerations in long-term intervention studies for the prevention of cognitive decline or Dementia.
- Breaking the diagnosis of Dementia.
- Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer Disease.
- Silence science: the problem of not reporting negative trials.
- Regulatory perspectives: one academic viewpoint from the United States.
- Estimating risk curves for first-degree relatives of patients with Alzheimer's Disease: the REVEAL study.
- Biogerontology, "anti-aging medicine," and the challenges of human enhancement.
- Classification of the Dementias.
- Research advances in the neurology of Dementia.
- Susceptibility testing for Alzheimer''s Disease: race for the future.
- Anthropological contributions to the understanding of age-related cognitive impairment.
- ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly.
- ADCS Prevention Instrument Project: quality of life assessment (QOL).
- ADCS Prevention Instrument Project: overview and initial results.
- Genetic risk assessment for adult children of people with Alzheimer''s Disease: the Risk Evaluation and Education for Alzheimer''s Disease (REVEAL) study.
- Mild cognitive impairment--a confused concept?
- Why I no longer consult for drug companies.
- Quality of life in Dementias.
- National Institute of Health and Clinical Excellence decision processes supported by UK High Court: the debate about the value of Alzheimer''s Disease drugs continues.
- Disclosure of APOE genotype for risk of Alzheimer''s Disease.
- Banking on stories for healthier cognitive ageing.
- B-vitamins and fatty acids in the prevention and treatment of Alzheimer''s Disease and dementia: a systematic review.
- Quality of life: the bridge from the cholinergic basal foreBrain to cognitive science and bioethics.
- Describing the dying days of "Alzheimer''s Disease".
- Protecting life and lives: putting gene research in context.
- Changing perspectives regarding late-life Dementia.
- Regulatory aspects of mild cognitive impairment: toward a harmonized perspective.
Schools
Johns Hopkins University School Of Medicine
Johns Hopkins University Hospital
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Cerebrovascular Disease
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
University Hospitals Case Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Kerry H. Levin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seby John, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Haifa N. Alabri, MD |
|
|
Dr. Keith McKee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua Gordon, MD |
|
|
Dr. Kelly L. Andrzejewski, MD |
|
|
Dr. Meziane A. Guerch, MD
This Doctor is OpenDoctor Recommended.
|